Back
Eagle Pharmaceuticals Stock Price Chart
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
5
EGRX
Eagle Pharmaceuticals
Last Price:
2.12
Seasonality Move:
-3.84%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
Eagle Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.02 | Sell |
| 20-day SMA: | 3.64 | Sell |
| 50-day SMA: | 4.19 | Sell |
| 200-day SMA: | 4.82 | Sell |
| 8-day EMA: | 2.65 | Sell |
| 20-day EMA: | 3.44 | Sell |
| 50-day EMA: | 4.05 | Sell |
| 200-day EMA: | 6.38 | Sell |
Eagle Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.61 | Sell |
| Relative Strength Index (14 RSI): | 14.49 | Sell |
| Chaikin Money Flow: | -964229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.94 - 4.72) | Sell |
| Bollinger Bands (100): | (3.55 - 5.35) | Sell |
Eagle Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Eagle Pharmaceuticals Stock
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.90 while EGRX 8-day simple moving average is 3.02, which is a Sell signal.
- The stock price of EGRX is 0.90 while Eagle Pharmaceuticals 20-day SMA is 3.64, which makes it a Sell.
- Eagle Pharmaceuticals 50-day simple moving average is 4.19 while EGRX share price is 0.90, making it a Sell technically.
- EGRX stock price is 0.90 and Eagle Pharmaceuticals 200-day simple moving average is 4.82, creating a Sell signal.
EGRX Technical Analysis vs Fundamental Analysis
Sell
5
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy or a Sell?
-
Eagle Pharmaceuticals stock is rated a Sell
The current Eagle Pharmaceuticals [EGRX] share price is $0.90. The Score for EGRX is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
Eagle Pharmaceuticals Stock Info
Market Cap:
11.69M
Price in USD:
0.90
Share Volume:
1.27M
Eagle Pharmaceuticals 52-Week Range
52-Week High:
14.78
52-Week Low:
0.75
Sell
5
Eagle Pharmaceuticals (EGRX)
is a Sell
Eagle Pharmaceuticals Share Price Forecast
-
What is the Eagle Pharmaceuticals stock price today?
The Eagle Pharmaceuticals stock price is 0.90 USD today. -
Will EGRX stock go up or go down?
Eagle Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Eagle Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Eagle Pharmaceuticals is overvalued.
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.90 while EGRX 8-day exponential moving average is 2.65, which is a Sell signal.
- The stock price of EGRX is 0.90 while Eagle Pharmaceuticals 20-day EMA is 3.44, which makes it a Sell.
- Eagle Pharmaceuticals 50-day exponential moving average is 4.05 while EGRX share price is 0.90, making it a Sell technically.
- EGRX stock price is 0.90 and Eagle Pharmaceuticals 200-day simple moving average is 6.38, creating a Sell signal.
Fundamental Analysis of Eagle Pharmaceuticals
Is Eagle Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Eagle Pharmaceuticals
Should I short Eagle Pharmaceuticals stock?
- EGRX Moving Average Covergence Divergence (MACD) indicator is -0.61, suggesting Eagle Pharmaceuticals is a Sell
- Eagle Pharmaceuticals Relative Strength Index (RSI) is 14.49, which suggest Eagle Pharmaceuticals is oversold
- The Bollinger Bands (25) for Eagle Pharmaceuticals is (2.94 - 4.72), which suggest Eagle Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Eagle Pharmaceuticals is (3.55 - 5.35), which suggest Eagle Pharmaceuticals is a Sell
* Eagle Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.